Search

This is a protocol for a Cochrane Review (Intervention). The objectives are as follows: To assess the effects of melatonin for non‐respiratory sleep disorders in typically developing children, with regard to improvement in sleep initiation, sleep maintenance and sleep scheduling, when compared with placebo, other medication for sleep disorders, psychological/behavioural therapy, light therapy or no treatment.

This is a protocol for a Cochrane Review (Intervention). The objectives are as follows: To assess the role of melatonin for non‐respiratory sleep disorders in children with neurodevelopmental disorders for improvement in sleep initiation, sleep maintenance and sleep scheduling when compared with either placebo, other medication for sleep disorders, psychological/behavioural treatment, light therapy or no treatment.

Non-invasive monitoring of breathing is a holy grail in paediatric respiratory, neonatal and sleep medicine. Respiratory rate is a key marker for the surveillance of sick infants and children (1-3), while repeated infant apnoeic episodes are associated with an increased risk of apparent life-threatening events (4). In clinical pulse oximetry, the photoplethysmographic (pleth) signal is assessed mainly to infer the validity of measured arterial oxygen saturation. This article is protected by copyright. All rights reserved.

Background: In adults, ventilation is preferentially distributed towards the dependent lung. A reversal of the adult pattern has been observed in infants using radionuclide ventilation scanning. But these results have been obtained in infants and children with lung disease. In this study we investigate whether healthy infants have a similar reverse pattern of ventilation distribution. Study Design: Measurement of regional ventilation distribution in healthy newborn infants during non-REM sleep in comparison to adults. Methods: Twenty-four healthy newborns and 13 adults were investigated with electrical impedance tomography (EIT) in supine and prone position. Regional ventilation distribution was assessed with profiles of relative impedance change. The phase lag between dependent and non-dependent ventilation was calculated as a measure of asynchronous ventilation. Results: In newborns and adults the geometric center of ventilation was centrally located in the lung at 52.2 +/- 6.2% from anterior to posterior and at 50.5 +/- 14.7%, respectively Using impedance profiles, ventilation was equally distributed to the dependent and non-dependent lung regions in newborns. Ventilation distribution in adults was similar Phase lag characteristics of the impedance signal showed that infants had slower emptying of the dependent lung than adults. Conclusion: The speculated reverse pattern of regional ventilation distribution in healthy infants compared to adults could not be demonstrated. Gravity had little effect on ventilation distribution in both infants and adults measured in supine and prone position. Pediatr Pulmonol. 2009;44:851-858. (C) 2009 Wiley-Liss, Inc.

Aim: Polysomnography (PSG) is the current standard protocol for sleep disordered breathing (SDB) investigation in children. Presently, there are limited reliable screening tests for both central (CE) and obstructive (OE) respiratory events. This study compared three indices, derived from pulse oximetry and electrocardiogram ( ECG), with the PSG gold standard. These indices were heart rate (HR) variability, arterial blood oxygen de-saturation (SaO(2)) and pulse transit time (PTT). Methods: 15 children (12 male) from routine PSG studies were recruited (aged 3 - 14 years). The characteristics of the three indices were based on known criteria for respiratory events (RPE). Their estimation singly and in combination was evaluated with simultaneous scored PSG recordings. Results: 215 RPE and 215 tidal breathing events were analysed. For OE, the obtained sensitivity was HR (0.703), SaO(2) (0.047), PTT (0.750), considering all three indices (0) and either of the indices (0.828) while specificity was (0.891), (0.938), (0.922), (0.953) and (0.859) respectively. For CE, the sensitivity was HR (0.715), SaO(2) (0.278), PTT (0.662), considering all indices (0.040) and either of the indices (0.868) while specificity was (0.815), (0.954), (0.901), (0.960) and (0.762) accordingly. Conclusions: Preliminary findings herein suggest that the later combination of these non-invasive indices to be a promising screening method of SDB in children.

High-resolution computed tomography (HRCT) is a sensitive technique for early visualisation and location of cystic fibrosis (CF) bronchopathology, and has been shown to detect acute reversible and chronic changes. It would be expected to correlate with markers of the underlying pathological processes, such as sputum cytokines and cytology, as well as with pulmonary function tests (PFTs). Our aim was to study the relationship between PFTs, sputum cytology, and sputum cytokine interleukin-8 (IL-8) and HRCT in CIF patients. Prospective standardized collection of sputum samples was performed at the time of routine annual high-resolution CT scans. Forced expired volume in 1 sec (FEV1) and forced vital capacity (FVC) were recorded. Sputum processing was selective, with dispersal by the three-enzyme technique. IL-8 measurements were by kit assay. HRCT scans were scored by a pediatric radiologist, blinded to clinical condition, using a modified Bhalla score.Forty-three CT scans were performed on 34 children with CIF between March 1998 and April 2000. Mean age was 12.3 years (range, 6-21 years), FEV1 (% predicted) was 67% (range, 23-120%), and mean modified Bhalla score was 11.2 (range, 0-22). Sputum IL-8 concentration (mean, 86; range, 4-150 ng/mL) and total cell count (mean, 31.9 x 10(6)/mL; range, 21.8-42.0 x 10(6)/mL) were high. FEV1 and FVC correlated with modified Bhalla score (r = -0.66, P < 0.0001 for both), and most individual components of the score, especially mosaic perfusion (r = -0.64, r = -0.61 respectively, P < 0.0001) and extent of bronchiectasis (r = -0.61, P < 0.0001 for both). The combination of these two predicted 58% of the variability in FEV1 on analysis of variance (P < 0.0001). Sputum total cell count correlated weakly with modified Bhalla score (r = 0.38, P < 0.05) and with FEV1 and FVC (r = -0.36, P < 0.05; and r= -0.46, P < 0.01). Differential cell counts, cell viability, and IL-8 did not correlate with modified Bhalla scores, or with reversible components such as mucus plugging, centrilobular nodules, or peribronchial thickening.In conclusion, pathological changes on HRCT correlated with lung function but not with sputum markers of inflammation. (C) 2002 Wiley-Liss, Inc.

Objectives: A hospital admission for asthma represents an opportunity to address and improve asthma control. The aims of this study were to compare the ambulatory care of children admitted to the intensive care unit (ICU) following a life-threatening asthma exacerbation with published guidelines of asthma management and to identify areas that could be targeted for change.Methods: A retrospective review of case notes of children admitted to the ICU with asthma over a 6-month period. Variables recorded were: demographic; asthma history (including prior pattern of asthma, hospital admissions, interval treatment and managing doctor); admission details (consultation of respiratory team and asthma educator); and discharge management.Results: There were 40 admissions of 38 children (24 males) with mean age 5.7 years (range 1.1-14 years). The majority (58%) had previous admissions for asthma (55 admissions in 22 children), with 23% of these to ICU. Sixty three per cent of those with previous admissions had persistent asthma, but only 29% were on inhaled corticosteroid (ICS). Most (60%) were managed by their local medical officer (LMO). Use of ICS was more likely if managed by a paediatrician. A respiratory subspecialist was consulted in 42% and the asthma educator in 70% of ICU admissions. Discharge medication included ICS in 74%, with no interval treatment in 18% of admissions. Follow up was by a respiratory subspecialist in 25% of cases.Conclusion: Asthma management before and after admission with life-threatening asthma did not conform to available guidelines. Persistent asthma was under-treated. Paediatricians were more likely to use interval treatment than LMO. We identified areas in which quality of care and outcome could be improved in this vulnerable group of asthmatics.

Background: Children with Prader Willi syndrome (PWS) are at risk of sleep disordered breathing involving central and obstructive components. PWS patients are known to have abnormal responses to hypoxia and hypercapnoea, an increased incidence of Obstructive Sleep Apnoea [OSA] and hypersomnolence when older not explained by obesity alone. As infants, many present with delay in central control of breathing during sleep. Hypersomnolence and indeed narcolepsy have been reported in this group of patients. Modafinil is a wake promoting agent but a pharmacological profile that is distinct from sympathomimetic amines, which increase wakefulness by other mechanisms. Modafinil does not bind to most of the potentially relevant receptors for sleep/wake regulation, including those for noradrenaline, serotonin, dopamine, GABA, adenosine, histamine-3 and benzodiazepines. Methods: Polysomnography (PSG) and multiple sleep latency testing [MSLT] was performed on PWS children attending a multidisciplinary clinic. Children who met criteria for narcolepsy were treated according to narcolepsy guidelines. Those who were hypersomnolent were assessed and three patients were trialed on Modafinil (a novel wake promoting agent). Results: Three children were studied, aged 7–13 years. Two were treated within a placebo controlled cross-over design. There was a significant difference in behavioural parameters as measured by teacher and parent. The other had significant hypersomnolence with a BMI in the obese range. Treatment resulted in a dramatic improvement in behaviour, activity and BMI. Conclusion: Children with Prader Willi syndrome and hypersomnolence may benefit from treatment with modafinil.

Background: Children with Prader Willi syndrome (PWS) are at risk of sleep disordered breathing involving central and obstructive components. PWS patients are known to have abnormal responses to hypoxia and hypercapnoea, an increased incidence of Obstructive Sleep Apnoea [OSA] and hypersomnolence when older. As infants, many present with delay in central control of breathing during sleep and resultant hypoxia. This may have long term consequences for the phenotype. Methods: Polysomnography (PSG) and multiple sleep latency testing [MSLT] was performed on PWS children attending a multidisciplinary clinic. Sleep disorders and age of presentation were identified. EEG spectral analysis on infants was undertaken and compared to a group of typically developing infants. Genotype was established. Results: Results suggest that in children less than 2 years central hypoventilation is present in 100%. 10% of children older than five had normal studies and the rest had OSA+/central hypoventilation. 10% had central hypoventilation and hypersomnolence. Twenty-five children under 12 months of age were analysed separately. Improvements in central hypoventilation were seen in some infants as they matured. The relationship between this and development of mature EEG patterns was examined and is significantly different to EEG spectral analysis of normal infants studied at 3, 6 and 12 months. This was also related to the genotype of each infant. Conclusion: Infants with Prader Willi have a delay in neural maturity as reflected by EEG development of defined EEG sleep stages. All infants with Prader Willi should have a sleep study in infancy and appropriate therapy instigated if required. Hypersomnolence is generally associated with other sleep disorders.